Home > Clinical Trials

Saved trials

RECRUITING
NCT06916520
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE)
300 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Percutaneous Coronary Intervention (PCI)
ACTIVE_NOT_RECRUITING
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT04494425
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer
866 Enrollment(s)
293 Study location(s)
INTERVENTIONAL (PHASE3)
Advanced or Metastatic Breast Cancer
RECRUITING
NCT07217938
Novel Treatment of Radiation Associated Dysphagia With Statins
48 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Radiation-associated Dysphagia


Head &Amp; Neck Cancer
ACTIVE_NOT_RECRUITING
NCT04294628
Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
62 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Malignant Solid Neoplasm


Metastatic Malignant Solid Neoplasm


Refractory Malignant Solid Neoplasm


Unresectable Malignant Solid Neoplasm
COMPLETED
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
608 Enrollment(s)
227 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
ACTIVE_NOT_RECRUITING
NCT03950076
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
948 Enrollment(s)
152 Study location(s)
INTERVENTIONAL (PHASE4)
Intracranial Hemorrhages


Atrial Fibrillation